Company Filing History:
Years Active: 2016-2017
Title: Theresia Popow-Kraupp: Innovator in Pharmaceutical Science
Introduction
Theresia Popow-Kraupp is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceutical science, particularly in the development of diagnostic methods and vaccine carriers. With a total of 2 patents, her work has the potential to impact public health positively.
Latest Patents
One of her latest patents is a method for diagnosing a rhinovirus infection. This invention relates to a pharmaceutical composition that includes at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues. These residues comprise amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3, and VP4. Another significant patent is for a vaccine carrier, which involves a hypoallergenic protein made from at least one hypoallergenic molecule derived from an allergen. This molecule is fused or conjugated to at least one second non-allergenic protein or fragment thereof.
Career Highlights
Theresia has worked with several companies, including Viravaxx GmbH and Biomay AG. Her experience in these organizations has allowed her to develop innovative solutions in the pharmaceutical industry.
Collaborations
Some of her notable coworkers include Rudolf Valenta and Katarzyna Niespodziana. Their collaborative efforts have contributed to advancements in their respective fields.
Conclusion
Theresia Popow-Kraupp is a distinguished inventor whose work in pharmaceutical science continues to pave the way for innovative solutions in healthcare. Her patents reflect her commitment to improving diagnostic methods and vaccine development.